Alphatec Holdings, Inc. (ATEC) Income Statement Analysis

See more : Okapi Resources Limited (OKR.AX) Income Statement Analysis – Financial Results

Complete financial analysis of Alphatec Holdings, Inc. (ATEC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Alphatec Holdings, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.

You may be interested

General Insurance Corporation of India (GICRE.NS) Income Statement Analysis – Financial Results
Salzgitter AG (SZGPF) Income Statement Analysis – Financial Results
Lavvi Empreendimentos Imobiliários S.A. (LAVV3.SA) Income Statement Analysis – Financial Results
Angel Oak Mortgage, Inc. (AOMR) Income Statement Analysis – Financial Results
Saregama India Limited (SAREGAMA.NS) Income Statement Analysis – Financial Results

Alphatec Holdings, Inc. (ATEC)

Industry: Medical - Devices

Sector: Healthcare

Website: https://www.atecspine.com

About Alphatec Holdings, Inc.

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; squadron lateral retractor designed to maximize patient outcomes; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System that provides minimally invasive pedicle screw placement. It also provides Invictus Modular Fixation Systems designed to increase adaptability with the power of screw modularity; OsseoScrew system to restore the integrity of the spinal column; Arsenal spinal fixation system, a comprehensive thoracolumbar fixation platform to fix a range of degenerative to deformity pathologies and surgical procedures; Aspida Anterior Lumbar Plating System, a fixation system for anterior lumbar interbody fusion; AMP Anti-Migration Plate; OCT Spinal Fixation System; trestle luxe anterior cervical plate system; and Insignia Anterior Cervical Plate System. In addition, the company offers IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Interbody Implants; and biologics consisting of Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier, as well as EOS imaging products. It sells its products through a network of independent distributors and direct sales representatives in the United States. The company was founded in 1990 and is headquartered in Carlsbad, California.

Metric	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001
Revenue	482.26M	350.87M	243.21M	144.86M	113.43M	91.69M	101.74M	120.25M	185.28M	206.98M	204.72M	196.28M	197.71M	171.61M	132.16M	101.31M	80.03M	74.01M	42.33M	17.82M	10.89M	11.34M	13.96M
Cost of Revenue	172.06M	117.81M	85.45M	42.36M	35.83M	28.46M	39.41M	44.11M	63.74M	61.83M	78.67M	70.76M	80.78M	58.79M	48.02M	36.61M	29.82M	25.70M	17.72M	5.46M	0.00	4.50M	5.85M
Gross Profit	310.20M	233.06M	157.76M	102.50M	77.59M	63.24M	62.33M	76.13M	121.54M	145.15M	126.06M	125.52M	116.93M	112.82M	84.14M	64.71M	50.21M	48.31M	24.60M	12.36M	10.89M	6.84M	8.12M
Gross Profit Ratio	64.32%	66.42%	64.87%	70.76%	68.41%	68.97%	61.27%	63.31%	65.60%	70.13%	61.57%	63.95%	59.14%	65.74%	63.67%	63.87%	62.73%	65.27%	58.13%	69.36%	100.00%	60.32%	58.13%
Research & Development	70.12M	44.03M	32.02M	18.75M	13.85M	9.98M	4.92M	9.25M	18.04M	17.33M	14.19M	15.23M	16.89M	19.40M	13.49M	12.97M	6.36M	3.59M	4.07M	1.18M	0.00	415.00K	326.15K
General & Administrative	0.00	0.00	0.00	0.00	0.00	0.00	23.22M	26.34M	34.87M	43.38M	47.95M	39.94M	36.37M	34.75M	22.32M	23.36M	54.19M	66.83M	35.58M	11.01M	0.00	7.22M	7.51M
Selling & Marketing	0.00	0.00	0.00	0.00	0.00	72.51M	41.16M	50.96M	70.86M	77.18M	76.96M	75.18M	75.19M	66.54M	51.51M	42.44M	29.94M	33.10M	0.00	0.00	0.00	0.00	0.00
SG&A	374.08M	300.01M	229.27M	129.16M	101.71M	72.51M	64.38M	77.30M	105.72M	120.56M	124.91M	115.12M	111.56M	101.29M	73.83M	65.80M	54.19M	66.83M	35.58M	11.01M	0.00	7.22M	7.51M
Other Expenses	39.40M	10.12M	5.35M	688.00K	698.00K	738.00K	-133.00K	-715.00K	6.98M	-33.00K	-1.66M	-794.00K	2.15M	1.54M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Expenses	483.60M	354.16M	266.63M	148.59M	116.26M	83.23M	69.99M	87.48M	127.62M	142.60M	143.84M	134.27M	130.60M	122.22M	87.32M	89.76M	60.55M	70.42M	39.65M	12.18M	0.00	7.64M	7.84M
Cost & Expenses	655.66M	471.97M	352.08M	190.95M	152.09M	111.69M	109.39M	131.60M	191.36M	204.43M	222.51M	205.03M	211.38M	181.02M	135.33M	126.37M	90.37M	96.12M	57.37M	17.64M	0.00	12.14M	13.68M
Interest Income	0.00	5.51M	7.11M	12.37M	9.87M	0.00	0.00	3.00K	11.00K	10.00K	6.00K	118.00K	148.00K	81.00K	67.00K	374.00K	793.00K	701.00K	0.00	0.00	0.00	0.00	0.00
Interest Expense	16.64M	5.51M	7.11M	12.37M	0.00	7.14M	7.48M	15.56M	5.56M	13.64M	5.62M	6.78M	3.03M	4.70M	3.49M	1.88M	868.00K	2.13M	1.93M	311.51K	0.00	240.00K	0.00
Depreciation & Amortization	59.68M	43.93M	30.17M	11.63M	8.51M	6.79M	7.48M	12.36M	3.85M	4.71M	4.74M	3.93M	2.15M	1.54M	11.96M	8.73M	10.62M	9.02M	3.54M	633.85K	0.00	0.00	0.00
EBITDA	-110.59M	-102.58M	-106.88M	-54.84M	-48.63M	-13.21M	136.00K	-13.20M	-149.37M	20.21M	-48.81M	10.38M	-3.79M	6.71M	2.38M	-18.21M	-8.27M	-13.10M	-11.50M	1.55M	10.89M	-798.00K	277.21K
EBITDA Ratio	-22.93%	-31.50%	-43.21%	-31.34%	-25.88%	-21.00%	-0.30%	-8.66%	-1.20%	3.51%	-6.37%	-2.46%	-0.34%	-4.59%	-2.40%	-22.02%	11.84%	-14.99%	-26.90%	0.41%	100.00%	-7.04%	1.99%
Operating Income	-173.40M	-121.10M	-108.87M	-46.09M	-38.67M	-22.44M	-9.00M	-15.38M	-172.44M	1.84M	-73.43M	-9.84M	-24.52M	-11.79M	-9.56M	-27.81M	-19.69M	-22.11M	-15.04M	177.81K	10.89M	-798.00K	277.21K
Operating Income Ratio	-35.95%	-34.52%	-44.76%	-31.82%	-34.09%	-24.47%	-8.85%	-12.79%	-93.07%	0.89%	-35.87%	-5.01%	-12.40%	-6.87%	-7.23%	-27.45%	-24.60%	-29.88%	-35.54%	1.00%	100.00%	-7.04%	1.99%
Total Other Income/Expenses	-13.52M	-30.91M	-16.11M	-19.99M	-9.87M	-7.73M	4.43M	-15.56M	3.46M	-13.28M	-5.62M	-1.16M	-4.51M	-2.05M	-9.87M	-1.01M	74.00K	-3.43M	-2.05M	427.77K	-10.89M	-240.00K	-181.43K
Income Before Tax	-186.92M	-152.01M	-144.16M	-78.85M	-57.14M	-30.17M	-4.57M	-30.94M	-178.00M	-11.80M	-79.05M	-16.62M	-26.69M	-16.49M	-13.05M	-28.82M	-19.61M	-25.55M	-17.09M	605.58K	0.00	-1.04M	95.78K
Income Before Tax Ratio	-38.76%	-43.32%	-59.27%	-54.43%	-50.38%	-32.90%	-4.50%	-25.73%	-96.07%	-5.70%	-38.61%	-8.47%	-13.50%	-9.61%	-9.87%	-28.45%	-24.51%	-34.52%	-40.38%	3.40%	0.00%	-9.16%	0.69%
Income Tax Expense	-277.00K	140.00K	164.00K	145.00K	-239.00K	-1.36M	-34.00K	-4.49M	681.00K	1.09M	3.18M	-1.16M	-4.51M	-2.05M	243.00K	468.00K	590.00K	270.00K	-3.04M	96.13K	833.51K	4.00K	3.90K
Net Income	-186.64M	-152.15M	-144.33M	-78.99M	-56.90M	-28.98M	-2.29M	-30.32M	-178.68M	-12.88M	-82.23M	-15.46M	-22.18M	-14.36M	-13.29M	-29.29M	-20.20M	-25.82M	-14.05M	509.45K	-833.51K	-1.04M	91.88K
Net Income Ratio	-38.70%	-43.36%	-59.34%	-54.53%	-50.17%	-31.60%	-2.25%	-25.21%	-96.44%	-6.22%	-40.16%	-7.88%	-11.22%	-8.36%	-10.06%	-28.91%	-25.24%	-34.88%	-33.20%	2.86%	-7.65%	-9.19%	0.66%
EPS	-1.54	-1.47	-1.50	-1.18	-1.09	-0.82	-0.18	-3.53	-21.53	-1.59	-10.25	-2.06	-3.00	-2.19	-3.24	-7.59	-6.50	-11.37	-9.27	0.72	-1.08	-1.33	0.12
EPS Diluted	-1.54	-1.47	-1.50	-1.18	-1.09	-0.82	-0.17	-3.53	-21.53	-1.58	-10.25	-2.06	-3.00	-2.19	-3.24	-7.59	-6.50	-11.37	-9.27	0.60	-1.08	-1.33	0.12
Weighted Avg Shares Out	121.24M	103.37M	96.20M	67.02M	52.23M	35.32M	12.79M	8.58M	8.30M	8.11M	8.02M	7.52M	7.40M	6.55M	4.11M	3.86M	3.11M	2.27M	1.52M	764.91K	774.84K	786.00K	785.90K
Weighted Avg Shares Out (Dil)	121.24M	103.37M	96.20M	67.02M	52.23M	35.32M	13.28M	8.58M	8.30M	8.14M	8.02M	7.52M	7.40M	6.55M	4.11M	3.86M	3.11M	2.27M	1.52M	801.69K	774.84K	786.00K	792.51K

Alphatec Holdings, Inc. (ATEC) Q3 2024 Earnings Call Transcript

October 30, 2024seekingalpha.com

Alphatec Holdings, Inc. (NASDAQ:ATEC ) Q3 2024 Earnings Conference Call October 30, 2024 4:30 PM ET Company Participants Pat Miles - Chairman and CEO Todd Koning - CFO Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Mathew Blackman...

Alphatec (ATEC) Reports Q3 Loss, Tops Revenue Estimates

October 30, 2024zacks.com

Alphatec (ATEC) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.35 per share a year ago.

ATEC Reports Third Quarter 2024 Financial Results And Raises Full-Year Guidance

October 30, 2024businesswire.com

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended September 30, 2024, and recent corporate highlights. Third Quarter 2024 Financial Results...

ATEC to Report Third Quarter Financial Results on October 30, 2024

October 7, 2024businesswire.com

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report third quarter 2024 financial results on October 30, 2024, after the market close. The...